{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:15:52Z","timestamp":1790698552581,"version":"4.1.0"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":47,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Chiesi USA Inc."}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Limited studies have provided guidance on the optimal systolic blood pressure (SBP) after mechanical thrombectomy (MT) in acute ischemic stroke patients. In the Clevidipine Infusion for Blood Pressure Management After Successful Revascularization in Acute Ischemic Stroke (CLEVER) trial, our aim was to study the safety and efficacy of intensive SBP control with a Clevidipine infusion as the first-line agent.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The CLEVER trial was an investigator-initiated, single-center, open-label, randomized, controlled trial. Patients were randomized 1:1 to a SBP goal after successful MT (mTICI 2c or greater) of either 90-120mmHg (Intensive BP Management) or 90-160mmHg (Standard BP Management). The primary outcomes were time to target blood pressure and incidence of any hemorrhagic conversion at 24 hours.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Between October 2021 and December 2023, 80 eligible patients were enrolled, 40 each into the intensive BP and the standard BP management cohorts. Overall, 72% of all BP measurements in the intensive BP management group were within the target range, compared to 93% in the standard BP management group (p&amp;lt;0.001). The median time from the initiation of Clevidipine infusion until reaching the target SBP was significantly shorter in the standard BP management group, 10 minutes [IQR 5.0-45.0] versus 20 IQR 12.5-42.5] (95%CI:5.0-20.0, p=0.002). The incidence of hemorrhagic transformation per core lab was not significantly different in the intensive BP management group (32.5%) and the standard BP management group (35.0%); adjusted OR (0.93 [95%CI, 0.30-2.85]; p=0.89).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In the randomised CLEVER trial, intensive BP control using clevidipine after MT failed to reduce the rate of haemorrhagic conversion or sICH and resulted in a numerically lower rate of good clinical outcome compared to standard BP control. Clevidipine was well tolerated in both cohorts and demonstrated a similar safety profile. Larger studies are needed to understand the efficacy and safety of clevidipine for BP control and the optimal BP threshold after MT.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/esj\/aakag005","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T17:37:53Z","timestamp":1771349873000},"source":"Crossref","is-referenced-by-count":2,"title":["Clevidipine infusion for blood pressure management after successful revascularisation in acute ischaemic stroke: the CLEVER study"],"prefix":"10.1093","volume":"11","author":[{"given":"Mouhammad A","family":"Jumaa","sequence":"first","affiliation":[{"name":"Department of Neurology, ProMedica Toledo Hospital , Toledo, OH ,","place":["United States"]},{"name":"Department of Neurology, University of Toledo , Toledo, OH ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Gharaibeh","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Toledo , Toledo, OH ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard E","family":"Burgess","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Toledo , Toledo, OH ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Rao","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Toledo , Toledo, OH ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion J","family":"Oliver","sequence":"additional","affiliation":[{"name":"Department of Neurology, Advocate Aurora Health , Park Ridge, IL ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Mierzwa","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Toledo , Toledo, OH ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisham S","family":"Alhajala","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Toledo , Toledo, OH ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashan","family":"Ali","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Toledo , Toledo, OH ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashutosh P","family":"Jadhav","sequence":"additional","affiliation":[{"name":"Department of Neurology, Barrow Neurological Institute , Phoenix, AZ ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia C","family":"Castonguay","sequence":"additional","affiliation":[{"name":"Department of Neurology, ProMedica Toledo Hospital , Toledo, OH ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hijrah","family":"El-Sabae","sequence":"additional","affiliation":[{"name":"HAE MedSci Solutions , Irvine, CA ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed F","family":"Zaidi","sequence":"additional","affiliation":[{"name":"Department of Neurology, ProMedica Toledo Hospital , Toledo, OH ,","place":["United States"]},{"name":"Department of Neurology, University of Toledo , Toledo, OH ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"key":"2026021712374557600_ref1","doi-asserted-by":"crossref","first-page":"723461","DOI":"10.3389\/fneur.2021.723461","article-title":"Blood pressure management after endovascular thrombectomy","volume":"12","author":"Peng","year":"2021","journal-title":"Front Neurol"},{"key":"2026021712374557600_ref2","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1161\/HYPERTENSIONAHA.119.14230","article-title":"Association of blood pressure with outcomes in acute stroke thrombectomy","volume":"75","author":"Malhotra","year":"2020","journal-title":"Hypertension"},{"key":"2026021712374557600_ref3","doi-asserted-by":"publisher","first-page":"78","DOI":"10.5853\/jos.2018.02369","article-title":"Association of elevated blood pressure levels with outcomes in acute ischemic stroke patients treated with intravenous thrombolysis: a systematic review and meta-analysis","volume":"21","author":"Malhotra","year":"2019","journal-title":"J Stroke"},{"key":"2026021712374557600_ref4","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1136\/neurintsurg-2019-014846","article-title":"Association of maximal systolic blood pressure with poor outcome in patients with hyperattenuated lesions on immediate NCCT after mechanical thrombectomy","volume":"12","author":"Ding","year":"2020","journal-title":"J Neurointerv Surg"},{"key":"2026021712374557600_ref5","doi-asserted-by":"publisher","first-page":"e006167","DOI":"10.1161\/JAHA.117.006167","article-title":"Systolic blood pressure within 24 hours after thrombectomy for acute ischemic stroke correlates with outcome","volume":"6","author":"Mistry","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"2026021712374557600_ref6","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1161\/01.STR.0000143329.81997.8a","article-title":"Identifying thresholds for penumbra and irreversible tissue damage","volume":"35","author":"Heiss","year":"2004","journal-title":"Stroke"},{"key":"2026021712374557600_ref7","doi-asserted-by":"crossref","first-page":"106799","DOI":"10.1016\/j.jstrokecerebrovasdis.2022.106799","article-title":"Prediction of intracranial atherosclerotic acute large vessel occlusion by severe hypoperfusion volume growth rate","volume":"31","author":"Sun","year":"2022","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2026021712374557600_ref8","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","article-title":"Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"50","author":"Powers","year":"2019","journal-title":"Stroke"},{"key":"2026021712374557600_ref9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3390\/diseases12030053","article-title":"Pre-stroke antihypertensive therapy affects stroke severity and 3-month outcome of ischemic MCA-territory stroke","volume":"12","author":"Lakatos","year":"2024","journal-title":"Diseases"},{"key":"2026021712374557600_ref10","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1001\/jama.2023.14590","article-title":"Intensive vs conventional blood pressure lowering after endovascular thrombectomy in acute ischemic stroke: the OPTIMAL-BP randomized clinical trial","volume":"330","author":"Nam","year":"2023","journal-title":"JAMA"},{"key":"2026021712374557600_ref11","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/S0140-6736(22)01882-7","article-title":"Intensive blood pressure control after endovascular thrombectomy for acute ischaemic stroke (ENCHANTED2\/MT): a multicentre, open-label, blinded-endpoint, randomised controlled trial","volume":"400","author":"Yang","year":"2022","journal-title":"Lancet"},{"key":"2026021712374557600_ref12","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S1474-4422(20)30483-X","article-title":"Safety and efficacy of intensive blood pressure lowering after successful endovascular therapy in acute ischaemic stroke (BP-TARGET): a multicentre, open-label, randomised controlled trial","volume":"20","author":"Mazighi","year":"2021","journal-title":"Lancet Neurol"},{"key":"2026021712374557600_ref13","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1001\/jama.2023.14330","article-title":"Blood pressure management after endovascular therapy for acute ischemic stroke: the BEST-II randomized clinical trial","volume":"330","author":"Mistry","year":"2023","journal-title":"JAMA"},{"key":"2026021712374557600_ref14","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/ana.26907","article-title":"Blood pressure after successful endovascular therapy: a systematic review and meta-analysis of randomized control trials","volume":"95","author":"Gharaibeh","year":"2024","journal-title":"Ann Neurol"},{"key":"2026021712374557600_ref15","doi-asserted-by":"crossref","first-page":"6355","DOI":"10.1038\/s41598-024-54667-9","article-title":"The safety and efficacy of clevidipine for blood pressure management in neurocritical patients: a systematic review and meta-analysis","volume":"14","author":"Widiastuti","year":"2024","journal-title":"Sci Rep"},{"key":"2026021712374557600_ref16","doi-asserted-by":"crossref","first-page":"107644","DOI":"10.1016\/j.clineuro.2023.107644","article-title":"Comparison between clevidipine and nicardipine in cerebrovascular diseases: a systematic review and meta-analysis","volume":"227","author":"Seifi","year":"2023","journal-title":"Clin Neurol Neurosurg"},{"key":"2026021712374557600_ref17","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1213\/01.ane.0000281443.13712.b9","article-title":"Clevidipine effectively and rapidly controls blood pressure preoperatively in cardiac surgery patients: the results of the randomized, placebo-controlled efficacy study of clevidipine assessing its preoperative antihypertensive effect in cardiac Surgery-1","volume":"105","author":"Levy","year":"2007","journal-title":"Anesth Analg"},{"key":"2026021712374557600_ref18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1213\/ane.0b013e3181732e53","article-title":"Treatment of acute postoperative hypertension in cardiac surgery patients: an efficacy study of clevidipine assessing its postoperative antihypertensive effect in cardiac surgery-2 (ESCAPE-2), a randomized, double-blind, placebo-controlled trial","volume":"107","author":"Singla","year":"2008","journal-title":"Anesth Analg"},{"key":"2026021712374557600_ref19","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1213\/ane.0b013e31818240db","article-title":"The ECLIPSE trials: comparative studies of clevidipine to nitroglycerin, sodium nitroprusside, and nicardipine for acute hypertension treatment in cardiac surgery patients","volume":"107","author":"Aronson","year":"2008","journal-title":"Anesth Analg"},{"key":"2026021712374557600_ref20","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3109\/00207454.2013.836703","article-title":"Clevidipine for acute hypertension in patients with subarachnoid hemorrhage: a pilot study","volume":"124","author":"Varelas","year":"2014","journal-title":"Int J Neurosci"},{"key":"2026021712374557600_ref21","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1159\/000351149","article-title":"Clevidipine rapidly and safely reduces blood pressure in acute intracerebral hemorrhage: the ACCELERATE trial","volume":"36","author":"Graffagnino","year":"2013","journal-title":"Cerebrovasc Dis"},{"key":"2026021712374557600_ref22","first-page":"S67","article-title":"Clevidipine is safe and effective for rapid blood pressure control in patients with acute neurological injuries","volume":"40","author":"Polderman","year":"2014","journal-title":"Intensive Care Med"},{"key":"2026021712374557600_ref23","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1097\/ANA.0b013e3181e3077b","article-title":"Efficacy of clevidipine in controlling perioperative hypertension in neurosurgical patients: initial single-center experience","volume":"22","author":"Bekker","year":"2010","journal-title":"J Neurosurg Anesthesiol"},{"key":"2026021712374557600_ref24","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1056\/NEJMoa1603460","article-title":"ATACH-2 trial investigators and the neurological emergency treatment trials network. Intensive blood-pressure lowering in patients with acute cerebral Hemorrhage","volume":"375","author":"Qureshi","year":"2016","journal-title":"N Engl J Med"},{"key":"2026021712374557600_ref25","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1161\/STROKEAHA.115.010049","article-title":"The Heidelberg Bleeding Classification: classification of bleeding events after ischemic stroke and reperfusion therapy","volume":"46","author":"Kummer","year":"2015","journal-title":"Stroke"},{"key":"2026021712374557600_ref26","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1161\/STROKEAHA.119.027549","article-title":"Blood pressure variability and neurologic outcome after endovascular thrombectomy: a secondary analysis of the BEST study","volume":"51","author":"Mistry","year":"2020","journal-title":"Stroke"},{"key":"2026021712374557600_ref27","doi-asserted-by":"publisher","first-page":"e0375","DOI":"10.1097\/HPC.0000000000000375","article-title":"Emergency department and critical care use of clevidipine for treatment of hypertension in patients with acute stroke","volume":"24","author":"Brehaut","year":"2025","journal-title":"Crit Pathw Cardiol"}],"container-title":["European Stroke Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/esj\/article-pdf\/11\/2\/aakag005\/66964491\/aakag005.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/esj\/article-pdf\/11\/2\/aakag005\/66964491\/aakag005.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T17:37:55Z","timestamp":1771349875000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/esj\/article\/doi\/10.1093\/esj\/aakag005\/8488921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2,9]]}},"URL":"https:\/\/doi.org\/10.1093\/esj\/aakag005","relation":{},"ISSN":["2396-9873","2396-9881"],"issn-type":[{"value":"2396-9873","type":"print"},{"value":"2396-9881","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2026,1]]},"article-number":"aakag005"}}